Cancer is a leading cause of death worldwide and there are still limited options for cure.
Chemotherapy is the most significant treatment for cancer which increased survival rates …

Glioblastoma (GBM) is the most aggressive glial tumor of the central nervous system.
Despite intense scientific efforts, patients diagnosed with GBM and treated with the current …

Introduction Drug repurposing is a promising strategy to develop new treatments for
glioblastoma. In this phase II clinical trial, we evaluated the addition of chlorpromazine to …

Simple Summary Introducing novel and effective treatments against glioblastoma (GBM)
remains an arduous journey as reflected in the negative outcome of most clinical trials. The …

Glioblastoma (GBM, grade IV astrocytoma), the most frequently occurring primary brain
tumor, presents unique challenges to therapy due to its location, aggressive biological …

Glioblastoma (GBM) is the most frequent and lethal brain tumor, whose therapeutic outcome-
only partially effective with current schemes-places this disease among the unmet medical …

Antibiotic-resistant bacterial pathogens are a very challenging problem nowadays.
Helicobacter pylori is one of the most widespread and successful human pathogens since it …

Glioblastoma (GBM) is a fatal astrocytic glioma with poor prognosis and treatment
resistance. Repurposing potential FDA-approved drugs like anti-psychotics can address the …

Combination drug therapy addresses the auxiliary cancer pathways of the tumor
progression unaffected by the standard adjuvant treatments such as radio‐and …

Background Glioblastoma (GBM) is a devastating brain tumor with poor prognosis,
characterized by rapid growth and invasion into surrounding brain tissue. It is a hard-to-treat …